SHANNON ATKINSON: Open Payments
NPI 1841369147 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,312 in 156 payments from 21 companies in 2025. Trend: 2023 $3,336 · 2024 $21,844 · 2025 $26,312
Speaker / faculty: $20,485Food & beverage: $2,916Travel & lodging: $2,911
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 43 | $24,332 |
| ABBVIE INC. | 38 | $532 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $209 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $185 |
| Novo Nordisk Inc | 4 | $166 |
| Ardelyx, Inc. | 10 | $141 |
| PFIZER INC. | 7 | $107 |
| Lilly USA, LLC | 4 | $101 |
| Phathom Pharmaceuticals, Inc. | 9 | $85 |
| Janssen Scientific Affairs, LLC | 1 | $75 |
Products named: TREMFYA, STELARA, RINVOQ, ENTYVIO, XIFAXAN, Wegovy, IBSRELA, SKYRIZI.
Industry payments across KY — which companies pay providers there.
